Literature DB >> 11888651

Interleukin-7 negatively regulates the development of mature T cells in fetal thymus organ cultures.

Dominick DeLuca1, Dawn R Clark.   

Abstract

We added antibody specific for interleukin-7 (IL-7) to chimeric fetal thymus organ cultures (FTOC) to investigate the involvement of this cytokine at distinct stages of T cell development. We report that the neutralization of IL-7 early in fetal T cell development results in a decrease in the production of mature CD4 or CD8 ('single positive', SP) or CD4/8 negative ('double negative', DN) T cell phenotypes, as defined by their expression of CD3. This loss of T cell development was not complete, but it did include the development of gammadelta T cells. However, if IL-7 was neutralized at later stages of FTOC, the production of CD4/8 positive ('double positive', DP) T cells was increased, and if the addition of the antibody was delayed further, the production of mature SP T cells was increased. This last result could be extended to both alphabeta and gammadelta T cells. These data suggested that IL-7 played a negative regulatory role in the development of progressively mature T cells. Tissue sections of FTOC showed that IL-7 was expressed in the subcapsular region of the tissue where immature T cells reside. However, IL-7 was not detected in the medullary region where mature T cells are located. These data suggest that IL-7 not only supports the development of immature fetal T cells, but it may inhibit the development of mature T cells. The production of mature fetal T cells may, therefore, be delayed until their precursors enter the medullary microenvironment, where IL-7 production is low. In this way, T cells may be prevented from maturing until negative selection or anergy events eliminate or inactivate autoreactive clones.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2002        PMID: 11888651     DOI: 10.1016/s0145-305x(01)00085-4

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  5 in total

1.  Propensity of adult lymphoid progenitors to progress to DN2/3 stage thymocytes with Notch receptor ligation.

Authors:  Jiaxue Huang; Karla P Garrett; Rosana Pelayo; Juan Carlos Zúñiga-Pflücker; Howard T Petrie; Paul W Kincade
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

2.  Distinct roles of IL-7 and stem cell factor in the OP9-DL1 T-cell differentiation culture system.

Authors:  Hongfang Wang; L Jeanne Pierce; Gerald J Spangrude
Journal:  Exp Hematol       Date:  2006-12       Impact factor: 3.084

3.  Impaired thymopoiesis in interleukin-7 receptor transgenic mice is not corrected by Bcl-2.

Authors:  C Justin Van de Wiele; Julie H Marino; Chibing Tan; Hilary A Kneale; John Weber; John N Morelli; Brenda K Davis; Ashlee A Taylor; T Kent Teague
Journal:  Cell Immunol       Date:  2008-03-05       Impact factor: 4.868

4.  Perturbed thymopoiesis in vitro in the absence of suppressor of cytokine signalling 1 and 3.

Authors:  Hayley A Croom; David J Izon; Mark M Chong; David J Curtis; Andrew W Roberts; Thomas W H Kay; Douglas J Hilton; Warren S Alexander; Robyn Starr
Journal:  Mol Immunol       Date:  2008-03-05       Impact factor: 4.407

5.  Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia.

Authors:  Frederique Ponchel; Robert J Verburg; Sarah J Bingham; Andrew K Brown; John Moore; Andrew Protheroe; Kath Short; Catherine A Lawson; Ann W Morgan; Mark Quinn; Maya Buch; Sarah L Field; Sarah L Maltby; Aurelie Masurel; Susan H Douglas; Liz Straszynski; Ursula Fearon; Douglas J Veale; Poulam Patel; Dennis McGonagle; John Snowden; Alexander F Markham; David Ma; Jacob M van Laar; Helen A Papadaki; Paul Emery; John D Isaacs
Journal:  Arthritis Res Ther       Date:  2004-11-16       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.